book chapter · Advances in bioinformatics and biomedical engineering book series
Neurodegenerative disorders (NDD) are chronic conditions that lead to nerve cells degeneration in the central nervous system. The most common NDD are Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Huntington's disease (HD). Parkinson's disease (PD) is recognized as the second most common neurodegenerative disease after Alzheimer's disease (AD) and Huntington disease (HD). Astrocytes reprogramming has been recently proposed as one of the most important treatments to stop the progression of these neurological diseases. By targeting the microRNA, astrocytes in the animal brain could be reprogrammed into various functional neural systems. Activation of endogenous genes could be a revolutionary therapeutic approach for treating neurological diseases. Reprogrammed astrocytes could also be used to generate various types of neurons lost in case of Huntington's disease, Parkinson's disease, and Alzheimer's disease. The ability to reprogram astrocytes into functional neurons was classified as a new advancement for PD, AD, and HD treatments.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4018/978-1-6684-9675-6.ch016
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
